Delivery Order 75N93021D00018-75N98026F00004
Award Date 9/1/26
Potential Completion Date 8/31/27
Potential Value $1M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, MA 01887, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $448,478 delivery order to Charles River Laboratories, Inc. for the provision of influenza challenge virus under a firm fixed-price contract. The delivery order, issued on September 27, 2024, will be performed in Wilmington, Massachusetts, with an ultimate completion date of July 26, 2026. No set-aside designation was applied to this award, reflecting Charles River's competitive standing in federal procurement. Influenza...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Charles River Laboratories, Inc. on June 15, 2026, with a ceiling value of $339,743.00 for clinical trial materials supporting a human metapneumovirus pediatric respiratory virus vaccine (HMPV Lot #103), Task Order 12. Place of performance is Wilmington, MA. The order is firm fixed price with an ultimate completion date of June 14, 2027. No set-aside was used. The source does not identify the parent indefinite...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $131,254.50 firm fixed price delivery order to Charles River Laboratories, Inc. for clinical trial materials for virus vaccines. The contract has no set-aside designation. Performance will take place in Wilmington, Massachusetts with completion by June 9, 2022. The award is likely associated with the National Institute of Allergy and Infectious Diseases'...
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Charles River Laboratories, Inc. on December 16, 2020, with a ceiling value of $94,179.55 for provision of animals and specialized services. The order ultimate completion date was December 15, 2021. Place of performance is Wilmington, MA. The order was issued on a firm fixed price basis with no set-aside.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order to Charles River Laboratories, Inc. for universal influenza vaccine development support under the FY 2026 Undefined Delivery Order (UDO) Initiative. The contract, valued at approximately $2.0M, operates under a firm fixed-price delivery order model with a completion date of September 11, 2025. This modification primarily serves to de-obligate excess funds from the existing arrangement. The work will be...
- The National Institute of Allergy and Infectious Diseases issued a $371,635 delivery order to Charles River Laboratories, Inc. on August 19, 2026, for clinical trial materials supporting dengue virus vaccine development—specifically, CGMP preparation of a live DENV-4 clinical lot under Task Order 14. Place of performance is Wilmington, MA. The order carries a firm fixed price and is scheduled for completion by August 18, 2027. The source does not identify the parent vehicle by name; this...
- <p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $403,774.50 firm fixed price delivery order contract to Charles River Laboratories, Inc., doing business as Charles River, for coronavirus challenge virus support. The contract will be performed in Wilmington, Massachusetts over a one year period from July 25, 2022 through July 24, 2023. No subcontractors were identified.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded Charles River Laboratories, Inc. a $5.24M firm fixed price delivery order on September 30, 2025, for the preparation and characterization of five vaccine candidates. The work will be performed at Charles River's facility in Wilmington, Massachusetts, with an ultimate completion date of September 29, 2027. This delivery order was awarded without a set-aside designation, reflecting Charles River's competitive standing in...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Charles River Laboratories, Inc. on December 8, 2020, under the Laboratory Animal Diagnostic Testing Services IDIQ Contract 2 – CRL with a ceiling value of $47,448.96. Place of performance is Durham, NC. The order's ultimate completion date is June 16, 2026. This modification serves as a de-obligation of excess funds under the FY 2026 UDO Initiative. Pricing is firm fixed price with no set-aside applied.
- This is a firm-fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. (Charles River) to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $178,790.70 and a completion date of January 11, 2016. This order was placed under an existing indefinite delivery contract with Charles River, likely to support NIAID's ongoing...